Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

References

• WildSRoglicGGreenASicreeRKingHGlobal prevalence of diabetes estimates for the year 2000 and projections for 2030Diabetes Care20042751047105315111519
   PubMed Web of Science ®Google Scholar
• StrachanMWReynoldsRMMarioniREPriceJFCognitive function, dementia and type 2 diabetes mellitus in the elderlyNat Rev Endocrinol20117210811421263438
   PubMed Web of Science ®Google Scholar
• BiesselsGJStaekenborgSBrunnerEBrayneCScheltensPRisk of dementia in diabetes mellitus: a systematic reviewLancet Neurol200651647416361024
   PubMed Web of Science ®Google Scholar
• CukiermanTGersteinHWilliamsonJCognitive decline and dementia in diabetes – systematic overview of prospective observational studiesDiabetologia200548122460246916283246
   PubMed Web of Science ®Google Scholar
• StrachanMWDearyIJEwingFMFrierBMIs type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studiesDiabetes Care19972034384459051402
   PubMed Web of Science ®Google Scholar
• PrinceMBryceRAlbaneseEWimoARibeiroWFerriCPThe global prevalence of dementia: a systematic review and meta-analysisAlzheimers Dement201391637523305823
   PubMed Web of Science ®Google Scholar
• StrachanMWPriceJFFrierBMDiabetes, cognitive impairment, and dementiaBMJ20083367634618174567
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association2014 Alzheimer’s disease facts and figuresAlzheimers Dement2014102e47e9224818261
   PubMed Web of Science ®Google Scholar
• BeydounMALhotskyAWangYAssociation of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer’s diseaseAm J Epidemiol2008168101179118918835864
   PubMed Web of Science ®Google Scholar
• PeilaRRodriguezBLWhiteLRLaunerLJFasting insulin and incident dementia in an elderly population of Japanese–American menNeurology200463222823315277613
   PubMed Web of Science ®Google Scholar
• SjoholmANystromTInflammation and the etiology of type 2 diabetesDiabetes Metab Res Rev200622141015991254
   PubMed Web of Science ®Google Scholar
• LuchsingerJAType 2 diabetes and cognitive impairment: linking mechanismsJ Alzheimer’s Dis201230Suppl 2S185S19822433668
   PubMed Web of Science ®Google Scholar
• de la MonteSMContributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s diseaseDrugs2012721496622191795
   PubMed Web of Science ®Google Scholar
• LanctotKLRajaramRDHerrmannNTherapy for Alzheimer’s disease: how effective are current treatments?Ther Adv Neurol Disord20092316318021179526
   PubMedGoogle Scholar
• GreenRCSchneiderLSAmatoDAEffect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trialJAMA2009302232557256420009055
   PubMed Web of Science ®Google Scholar
• QuinnJFRamanRThomasRGDocosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trialJAMA2010304171903191121045096
   PubMed Web of Science ®Google Scholar
• QuerfurthHWLaFerlaFMAlzheimer’s diseaseN Engl J Med2010362432934420107219
   PubMed Web of Science ®Google Scholar
• SelkoeDJAlzheimer’s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-proteinJ Alzheimers Dis200131758012214075
   PubMed Web of Science ®Google Scholar
• MoreiraPISantosMSSeicaROliveiraCRBrain mitochondrial dysfunction as a link between Alzheimer’s disease and diabetesJ Neurol Sci20072571–220621417316694
   PubMed Web of Science ®Google Scholar
• MoreiraPIHondaKZhuXBrain and brawn: parallels in oxidative strengthNeurology2006662 Suppl 1S97S10116432155
   PubMed Web of Science ®Google Scholar
• GoedertMSpillantiniMGA century of Alzheimer’s diseaseScience2006314580077778117082447
   PubMed Web of Science ®Google Scholar
• HardyJAllsopDAmyloid deposition as the central event in the aetiology of Alzheimer’s diseaseTrends Pharmacol Sci199112103833881763432
   PubMed Web of Science ®Google Scholar
• HardyJSelkoeDJThe amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeuticsScience2002297558035335612130773
   PubMed Web of Science ®Google Scholar
• HardyJAHigginsGAAlzheimer’s disease: the amyloid cascade hypothesisScience199225650541841851566067
   PubMed Web of Science ®Google Scholar
• RocchiAPellegriniSSicilianoGMurriLCausative and susceptibility genes for Alzheimer’s disease: a reviewBrain Res Bull200361112412788204
   PubMed Web of Science ®Google Scholar
• CummingsJLAlzheimer’s diseaseN Engl J Med20043511566715229308
   PubMed Web of Science ®Google Scholar
• SmithADYaffeKDementia (including Alzheimer’s disease) can be prevented: statement supported by international expertsJ Alzheimers Disease201438469970324326609
   PubMed Web of Science ®Google Scholar
• DeFronzoRALilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDMDiabetes19883766676873289989
   PubMed Web of Science ®Google Scholar
• StefanNKantartzisKMachannJIdentification and characterization of metabolically benign obesity in humansArch Intern Med2008168151609161618695074
   PubMedGoogle Scholar
• LuchsingerJAGustafsonDRAdiposity, type 2 diabetes, and Alzheimer’s diseaseJ Alzheimers Disease200916469370419387106
   PubMed Web of Science ®Google Scholar
• OttAStolkRPvan HarskampFPolsHAHofmanABretelerMMDiabetes mellitus and the risk of dementia: the Rotterdam StudyNeurology19995391937194210599761
   PubMed Web of Science ®Google Scholar
• LuchsingerJReitzCHonigLSTangM-XSheaSMayeuxRAggregation of vascular risk factors and risk of incident Alzheimer diseaseNeurology200565454555116116114
   PubMed Web of Science ®Google Scholar
• GudalaKBansalDSchifanoFBhansaliADiabetes mellitus and risk of dementia: a meta-analysis of prospective observational studiesJ Diabetes Investig201346640650
   PubMed Web of Science ®Google Scholar
• ChengGHuangCDengHWangHDiabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studiesIntern Med J201242548449122372522
   PubMed Web of Science ®Google Scholar
• CurbJDRodriguezBLAbbottRDLongitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose toleranceNeurology199952597197510102414
   PubMed Web of Science ®Google Scholar
• WhitmerRASidneySSelbyJJohnstonSCYaffeKMidlife cardiovascular risk factors and risk of dementia in late lifeNeurology200564227728115668425
   PubMed Web of Science ®Google Scholar
• Schnaider BeeriMGoldbourtUSilvermanJMDiabetes mellitus in midlife and the risk of dementia three decades laterNeurology200463101902190715557509
   PubMed Web of Science ®Google Scholar
• PeilaRRodriguezBLLaunerLJType 2 diabetes, APOE gene, and the risk for dementia and related pathologies The Honolulu-Asia Aging StudyDiabetes20025141256126211916953
   PubMed Web of Science ®Google Scholar
• TakedaMMartinezRKudoTApolipoprotein E and central nervous system disorders: reviews of clinical findingsPsychiatry Clin Neurosci201064659260721105952
   PubMed Web of Science ®Google Scholar
• IrieFFitzpatrickALLopezOLEnhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition StudyArch Neurol2008651899318195144
   PubMed Web of Science ®Google Scholar
• DoreGAEliasMFRobbinsMAEliasPKNagyZPresence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse StudyDiabetologia200952122551256019693485
   PubMed Web of Science ®Google Scholar
• YaffeKBlackwellTWhitmerRAKruegerKBarrett ConnorEGlycosylated hemoglobin level and development of mild cognitive impairment or dementia in older womenJ Nutr Health Aging200610429329516886099
   PubMed Web of Science ®Google Scholar
• XuWLQiuCXWahlinAWinbladBFratiglioniLDiabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up studyNeurology20046371181118615477535
   PubMed Web of Science ®Google Scholar
• ProfennoLAPorsteinssonAPFaraoneSVMeta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disordersBiol Psychiatry201067650551219358976
   PubMed Web of Science ®Google Scholar
• ReavenGMLawsAInsulin Resistance: The Metabolic Syndrome XClifton, NJ, USAHuman Press1999
   Google Scholar
• AnsteyKCherbuinNBudgeMYoungJBody mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studiesObes Rev2011125e426e43721348917
   PubMed Web of Science ®Google Scholar
• GustafsonDRothenbergEBlennowKSteenBSkoogIAn 18-year follow-up of overweight and risk of Alzheimer diseaseArch Intern Med2003163131524152812860573
   PubMedGoogle Scholar
• FitzpatrickALKullerLHLopezOLMidlife and late-life obesity and the risk of dementia: cardiovascular health studyArch Neurol200966333634219273752
   PubMedGoogle Scholar
• WhitmerRAThe epidemiology of adiposity and dementiaCurr Alzheimer Res20074211712217430233
   PubMed Web of Science ®Google Scholar
• MorleyJEAnorexia, sarcopenia, and agingNutrition200117766066311448592
   PubMed Web of Science ®Google Scholar
• JohnsonDKWilkinsCHMorrisJCAccelerated weight loss may precede diagnosis in Alzheimer diseaseArch Neurol20066391312131716966511
   PubMedGoogle Scholar
• LuchsingerJATangM-XSheaSMayeuxRHyperinsulinemia and risk of Alzheimer diseaseNeurology20046371187119215477536
   PubMed Web of Science ®Google Scholar
• OkerekeOHankinsonSEHuFBGrodsteinFPlasma C peptide level and cognitive function among older women without diabetes mellitusArch Intern Med2005165141651165616043685
   PubMedGoogle Scholar
• OkerekeOIPollakMNHuFBHankinsonSESelkoeDJGrodsteinFPlasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetesPsychoneuroendocrinology200833445546118261857
   PubMed Web of Science ®Google Scholar
• OkerekeOIKurthTPollakMNGazianoJMGrodsteinFFasting plasma insulin, c-peptide and cognitive change in older men without diabetes: results from the Physicians’ Health Study IINeuroepidemiology201034420020720197703
   PubMed Web of Science ®Google Scholar
• AvogaroPCrepaldiGEnziGTiengoAAssociation of hyperlipemia, diabetes mellitus and mild obesityActa Diabetol Lat19674572590
   Google Scholar
• YaffeKKanayaALindquistKThe metabolic syndrome, inflammation, and risk of cognitive declineJAMA2004292182237224215536110
   PubMed Web of Science ®Google Scholar
• VanhanenMKoivistoKMoilanenLAssociation of metabolic syndrome with Alzheimer disease. A population-based studyNeurology200667584384716966548
   PubMed Web of Science ®Google Scholar
• KalmijnSFoleyDWhiteLMetabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia Aging StudyArterioscler Thromb Vasc Biol200020102255226011031212
   PubMed Web of Science ®Google Scholar
• RaffaitinCGinHEmpanaJ-PMetabolic syndrome and risk for incident Alzheimer’s disease or vascular dementia: the Three-City StudyDiabetes Care200932116917418945929
   PubMed Web of Science ®Google Scholar
• SolfrizziVScafatoECapursoCMetabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on AgeingJ Neurol Neurosurg Psychiatry201081443344019965842
   PubMed Web of Science ®Google Scholar
• MullerMTangM-XSchupfNManlyJJMayeuxRLuchsingerJAMetabolic syndrome and dementia risk in a multiethnic elderly cohortDement Geriatr Cogn Disord200724318519217641531
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIDanielsSRDiagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statementCirculation2005112172735275216157765
   PubMed Web of Science ®Google Scholar
• AlbertiKGZimmetPShawJIDF Epidemiology Task Force Consensus GroupThe metabolic syndrome – a new worldwide definitionLancet200536694911059106216182882
   PubMed Web of Science ®Google Scholar
• CrichtonGEEliasMFBuckleyJDMurphyKJBryanJFrisardiVMetabolic syndrome, cognitive performance, and dementiaJ Alzheimers Dis201230S77S8721971405
   PubMed Web of Science ®Google Scholar
• WattsASLoskutovaNBurnsJMJohnsonDKMetabolic syndrome and cognitive decline in early Alzheimer’s disease and healthy older adultsJ Alzheimers Dis201335225326523388170
   PubMed Web of Science ®Google Scholar
• ZhaoW-QDe FeliceFGFernandezSAmyloid beta oligomers induce impairment of neuronal insulin receptorsFASEB J200822124626017720802
   PubMed Web of Science ®Google Scholar
• MoloneyAMGriffinRJTimmonsSO’ConnorRRavidRO’NeillCDefects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signallingNeurobiol Aging201031222424318479783
   PubMed Web of Science ®Google Scholar
• SteenETerryBMRiveraEJImpaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease-is this type 3 diabetes?J Alzheimers Dis200571638015750215
   PubMed Web of Science ®Google Scholar
• HoyerSNitschRCerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer typeJ Neural Transm19897532272322926384
   PubMed Web of Science ®Google Scholar
• CraftSAlzheimer disease: insulin resistance and AD – extending the translational pathNat Rev Neurol20128736036222710630
   PubMed Web of Science ®Google Scholar
• TalbotKWangH-YKaziHDemonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineJ Clin Invest201212241316133822476197
   PubMed Web of Science ®Google Scholar
• HirosumiJTuncmanGChangLA central role for JNK in obesity and insulin resistanceNature2002420691333333612447443
   PubMed Web of Science ®Google Scholar
• BomfimTRForny-GermanoLSathlerLBAn anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomersJ Clin Invest201212241339135322476196
   PubMed Web of Science ®Google Scholar
• RiveraEJGoldinAFulmerNTavaresRWandsJRde la MonteSMInsulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholineJ Alzheimers Dis20058324726816340083
   PubMed Web of Science ®Google Scholar
• PhielCJWilsonCALeeVM-YKleinPSGSK-3α regulates production of Alzheimer’s disease amyloid-β peptidesNature2003423693843543912761548
   PubMed Web of Science ®Google Scholar
• WadaAYokooHYanagitaTKobayashiHNew twist on neuronal insulin receptor signaling in health, disease, and therapeuticsJ Pharmacol Sci200599212814316210778
   PubMed Web of Science ®Google Scholar
• CarroETrejoJLSpuchCBohlDHeardJMTorres-AlemanIBlockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer’s-like neuropathology in rodents: new cues into the human disease?Neurobiol Aging200627111618163116274856
   PubMed Web of Science ®Google Scholar
• CarroETorres-AlemanIThe role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer’s diseaseEur J Pharmacol2004490112713315094079
   PubMed Web of Science ®Google Scholar
• BakerLDCrossDJMinoshimaSBelongiaDWatsonGSCraftSInsulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetesArch Neurol2011681515720837822
   PubMedGoogle Scholar
• DeviLAlldredMJGinsbergSDOhnoMMechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer’s diseasePLoS One201273e3279222403710
   PubMed Web of Science ®Google Scholar
• PlumLSchubertMBrüningJCThe role of insulin receptor signaling in the brainTrends Endocrinol Metab2005162596515734146
   PubMed Web of Science ®Google Scholar
• GaspariniLNetzerWJGreengardPXuHDoes insulin dysfunction play a role in Alzheimer’s disease?Trends Pharmacol Sci200223628829312084635
   PubMed Web of Science ®Google Scholar
• KremerALouisJVJaworskiTVan LeuvenFGSK3 and Alzheimer’s disease: facts and fictionFront Mol Neurosci201141721904524
   PubMed Web of Science ®Google Scholar
• LiXLuFTianQYangYWangQWangJZActivation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in cultureJ Neural Transm200611319310215959856
   PubMed Web of Science ®Google Scholar
• PiconePGiacomazzaDVetriVInsulin-activated Akt rescues Aβ oxidative stress-induced cell death by orchestrating molecular traffickingAging Cell201110583284321624038
   PubMed Web of Science ®Google Scholar
• SuzanneMContributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s diseaseDrugs2012721496622191795
   PubMed Web of Science ®Google Scholar
• ThorneRPronkGPadmanabhanVFreyWH2ndDelivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administrationNeuroscience2004127248149615262337
   PubMed Web of Science ®Google Scholar
• RegerMWatsonGGreenPIntranasal insulin improves cognition and modulates β-amyloid in early ADNeurology200870644044817942819
   PubMed Web of Science ®Google Scholar
• CraftSBakerLDMontineTJIntranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialArch Neurol2012691293821911655
   PubMed Web of Science ®Google Scholar
• RegerMWatsonGFreyWH2ndEffects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotypeNeurobiol Aging200627345145815964100
   PubMed Web of Science ®Google Scholar
• KitabchiAETemprosaMKnowlerWCDiabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metforminDiabetes20055482404241416046308
   PubMed Web of Science ®Google Scholar
• GoldbergRHortonEMarcovinaSIntensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose toleranceDiabetes20055451566157215855347
   PubMed Web of Science ®Google Scholar
• OrchardTJTemprosaMGoldbergRThe effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trialAnn Intern Med2005142861161915838067
   PubMed Web of Science ®Google Scholar
• KnowlerWCBarrett-ConnorEFowlerSEReduction in the incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med2002346639340311832527
   PubMed Web of Science ®Google Scholar
• EvansJMDonnellyLAEmslie-SmithAMAlessiDRMorrisADMetformin and reduced risk of cancer in diabetic patientsBMJ200533075031304130515849206
   PubMed Web of Science ®Google Scholar
• CurrieCPooleCGaleEThe influence of glucose-lowering therapies on cancer risk in type 2 diabetesDiabetologia20095291766177719572116
   PubMed Web of Science ®Google Scholar
• DomínguezROMarschoffERGonzálezSERepettoMGSerraJAType 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer’s disease patientsDiabetes Res Clin Pract2012981687422658669
   PubMed Web of Science ®Google Scholar
• HsuC-CWahlqvistMLLeeM-STsaiH-NIncidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metforminJ Alzheimers Dis201124348549321297276
   PubMed Web of Science ®Google Scholar
• ImfeldPBodmerMJickSSMeierCRMetformin, other antidiabetic drugs, and risk of Alzheimer’s disease: a population-based case-control studyJ Am Geriatr Soc201260591692122458300
   PubMed Web of Science ®Google Scholar
• Yki-JärvinenHThiazolidinedionesN Engl J Med2004351111106111815356308
   PubMed Web of Science ®Google Scholar
• MalinowskiJMBolestaSRosiglitazone in the treatment of type 2 diabetes mellitus: a critical reviewClin Ther200022101151116811110228
   PubMed Web of Science ®Google Scholar
• NestoRC-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinedionesDiabet Med200421881081715270782
   PubMed Web of Science ®Google Scholar
• TuppoEEAriasHRThe role of inflammation in Alzheimer’s diseaseInt J Biochem Cell Biol200537228930515474976
   PubMed Web of Science ®Google Scholar
• CraftSInsulin resistance and Alzheimers disease pathogenesis: potential mechanisms and implications for treatmentCurr Alzheimer Res20074214715217430239
   PubMed Web of Science ®Google Scholar
• WatsonGCholertonBARegerMAPreserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary studyAm J Geriatr Psychiatry2005131195095816286438
   PubMed Web of Science ®Google Scholar
• RisnerMSaundersAAltmanJEfficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s diseasePharmacogenomics J20066424625416446752
   PubMed Web of Science ®Google Scholar
• GoldMAldertonCZvartau-HindMRosiglitazone monotherapy in mild-to-moderate Alzheimer’s disease: results from a randomized, double-blind, placebo-controlled phase III studyDement Geriatr Cogn Disord201030213114620733306
   PubMed Web of Science ®Google Scholar
• MillerBWWillettKCDesiletsARRosiglitazone and pioglitazone for the treatment of Alzheimer’s diseaseAnn Pharmacother201145111416142422028424
   PubMed Web of Science ®Google Scholar
• CheungBMBehind the rosiglitazone controversyExpert Rev Clin Pharmacol20103672372522111775
   PubMed Web of Science ®Google Scholar
• DeaconCFAhrénBPhysiology of incretins in health and diseaseRev Diabet Stud20118329322262068
   PubMedGoogle Scholar
• DruckerDJNauckMAThe incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesLancet200636895481696170517098089
   PubMed Web of Science ®Google Scholar
• DeaconCDipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative reviewDiabetes Obes Metab201113171821114598
   PubMed Web of Science ®Google Scholar
• LovshinJADruckerDJIncretin-based therapies for type 2 diabetes mellitusNat Rev Endocrinol20095526226919444259
   PubMed Web of Science ®Google Scholar
• VilsbøllTKrarupTMadsbadSHolstJJBoth GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjectsRegul Pept2003114211512112832099
   PubMedGoogle Scholar
• DuringMJCaoLZuzgaDSGlucagon-like peptide-1 receptor is involved in learning and neuroprotectionNat Med2003991173117912925848
   PubMed Web of Science ®Google Scholar
• AbbasTFaivreEHölscherCImpairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer’s diseaseBehav Brain Res2009205126527119573562
   PubMed Web of Science ®Google Scholar
• McCleanPLParthsarathyVFaivreEHölscherCThe diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s diseaseJ Neurosci201131176587659421525299
   PubMed Web of Science ®Google Scholar
• SelkoeDJPreventing Alzheimer’s diseaseScience201233761011488149222997326
   PubMed Web of Science ®Google Scholar
• PipatpiboonNPintanaHPratchayasakulWChattipakornNChattipakornSCDPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumptionEur J Neurosci201337583984923240760
   PubMed Web of Science ®Google Scholar
• PintanaHApaijaiNChattipakornNChattipakornSCDPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant ratsJ Endocrinol2013218111123591914
   PubMed Web of Science ®Google Scholar
• TyasSLManfredaJStrainLAMontgomeryPRRisk factors for Alzheimer’s disease: a population-based, longitudinal study in Manitoba, CanadaInt J Epidemiol200130359059711416089
   PubMed Web of Science ®Google Scholar
• MacKnightCRockwoodKAwaltEMcDowellIDiabetes mellitus and the risk of dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian Study of Health and AgingDement Geriatr Cogn Disord2002142778312145454
   PubMed Web of Science ®Google Scholar
• HassingLBJohanssonBNilssonSEDiabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer’s disease: a population-based study of the oldest oldInt Psychogeriatr200214323924812475085
   PubMed Web of Science ®Google Scholar
• HonigLSTangMXAlbertSStroke and the risk of Alzheimer diseaseArch Neurol200360121707171214676044
   PubMedGoogle Scholar
• ArvanitakisZWilsonRSBieniasJLEvansDABennettDADiabetes mellitus and risk of Alzheimer disease and decline in cognitive functionArch Neurol200461566166615148141
   PubMed Web of Science ®Google Scholar
• BorensteinARWuYMortimerJADevelopmental and vascular risk factors for Alzheimer’s diseaseNeurobiol Aging200526332533415639310
   PubMed Web of Science ®Google Scholar
• HaydenKMZandiPPLyketsosCGVascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County studyAlzheimer Dis Assoc Disord20062029310016772744
   PubMed Web of Science ®Google Scholar
• AkomolafeABeiserAMeigsJBDiabetes mellitus and risk of developing Alzheimer disease: results from the Framingham StudyArch Neurol200663111551155517101823
   PubMedGoogle Scholar
• AhtiluotoSPolvikoskiTPeltonenMDiabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic studyNeurology201075131195120220739645
   PubMed Web of Science ®Google Scholar
• OharaTDoiYNinomiyaTGlucose tolerance status and risk of dementia in the community: the Hisayama studyNeurology201177121126113421931106
   PubMed Web of Science ®Google Scholar
• ChengDNobleJTangMXSchupfNMayeuxRLuchsingerJAType 2 diabetes and late-onset Alzheimer’s diseaseDement Geriatr Cogn Disord201131642443021757907
   PubMed Web of Science ®Google Scholar
• LiJWangYJZhangMVascular risk factors promote conversion from mild cognitive impairment to Alzheimer diseaseNeurology201176171485149121490316
   PubMed Web of Science ®Google Scholar